Author

I. Pokataev

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Induction chemo-immunotherapy followed by surgery or radiotherapy for locally-advanced III stage non-small cell lung cancer: prospective single center non-randomized study (preliminary results)

Background. The evolving modalities of systemic treatment for non-small cell lung cancer (NSCLC) promotes the need to redefine different strategies for combined treatment in stage III and borderline-resectable lung cancer. Hereby we present the outcomes of a neoadjuvant chemo-immunotherapy regimen with subsequent in...

Y. Esakov, O. A. Kuchevskaya, I. Pokataev et al. · Malignant tumours · 0 citations

Open access Sep 2026

Efficacy and safety profile of dMMR/MSI immunotherapy in metastatic colorectal cancer in real-world clinical practice

Introduction. Deficiency of the mismatch repair system (dMMR) and microsatellite instability (MSI) occur in only 4–5% of patients with metastatic colorectal cancer (mCRC), but this molecular subgroup is characterized by high sensitivity to immune checkpoint inhibitors. Data on the efficacy and safety of such thera...

M. Lyadova, O. N. Zauzolkov, Julia S. Mansurova et al. · Meditsinskiy sovet = Medical... · 0 citations

Open access Sep 2026

The RATIONALE study: Outcomes of targeted therapy for metastatic melanoma in Russia

In real-world clinical practice, BRAF/MEK targeted therapy has demonstrated effectiveness in the Russian patient population, with outcomes consistent with those observed in randomized clinical trials, despite substantial population heterogeneity and the inclusion of patients with unfavorable prognostic factors.

I. Samoylenko, K. Orlova, N. V. Leushina et al. · Meditsinskiy sovet = Medical... · 0 citations